Ng TT, Denning DW. Liposomal amphotericin B (AmBisome) therapy in invasive fungal infections. Evaluation of United Kingdom compassionate use data.
Arch Intern Med 1995;155:1093-8.
121.
Noskin GA, Pietrelli L, Coffey G, et al. Amphotericin B colloidal dispersion for treatment
of candidemia in immunocompromised patients.
Clin Infect Dis 1998;26:461-7.
122.
Mehta J, Kelsey S, Chu P, et al. Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies.
Bone Marrow Transplant 1997;20:39-43.
123.
Walsh TJ, Hiemenz JW, Seibel NL, et al. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.
Clin Infect Dis 1998;26:1383-96.
124.
Walsh TJ, Seibel NL, Arndt C, et al. Amphotericin B lipid complex in pediatric patients with invasive fungal infections.
Pediatr Infect Dis J
1999;18:702-8.
125.
Wingard JR. Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses.
Bone Marrow Transplant 1997;19:343-7.